Clinical Trials Browser

Unknown × OTHER × Nasopharyngeal Neoplasms × Clear all

NCT05385926 2024-02-05

Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Neoplasms

NCT05198479 2023-10-11

SG-AAA-II-01

Phase 2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT04850235 2023-06-22

Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study

Phase 1 Unknown

Nasopharyngeal Neoplasms

NCT00941538 2023-02-28

CRCSTNPC

Phase NA Unknown

87,600 enrolled

Nasopharyngeal Neoplasms

NCT03837808 2022-11-07

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Phase 3 Unknown

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT04978012 2022-06-07

Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy

Phase 2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT03854838 2022-04-29

IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.

Phase 2 Unknown

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

NCT03942380 2021-09-21

Cell-free Tumor DNA in Head and Neck Cancer Patients

Phase NA Unknown

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms

NCT03129412 2020-09-17

Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions

Phase 2 Unknown

Nasopharyngeal Neoplasms, Neoplasm Metastasis

NCT04476641 2020-07-20

DC-CIK

Phase 2 Unknown

BreastGastrointestinalGenitourinaryHead & NeckThoracic

Breast Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Colorectal Neoplasms

NCT02627807 2020-06-16

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Phase NA Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT01844557 2019-09-11

Testing Accountability in Patient Adherence

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms

NCT02902432 2019-01-31

A Trial of Endostar in Patients With Carcinoma of the Head and Neck

Phase 2 Unknown

Nasopharyngeal Neoplasms

NCT03619824 2018-10-09

PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Neoplasms

NCT02507154 2018-08-21

NKEXPHNC

Phase 1/2 Unknown

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms

NCT02211677 2018-06-20

Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

NCT03282617 2017-09-14

Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1 Unknown

Nasopharyngeal Neoplasms

NCT01762514 2017-07-13

A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens

Phase 2 Unknown

Head & NeckOther

Nasopharyngeal Carcinoma, Bone Marrow Diseases, Nasopharyngeal Neoplasms, Salivary Gland Diseases, Xerostomia, Mucositis

NCT02945878 2017-06-28

Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms, Stomatitis

NCT03003182 2017-06-15

A Study of Nasopharyngeal Carcinoma From Guangdong

Nasopharyngeal Neoplasms

NCT03093649 2017-03-28

Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma

Phase NA Unknown

Nasopharyngeal Neoplasms

NCT02980315 2016-12-02

A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application

Phase 1/2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT02735317 2016-04-12

Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Phase 2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Stomatitis

NCT02729324 2016-04-06

Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Phase 2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Radiodermatitis

NCT02250599 2015-12-30

Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT01074021 2015-10-30

Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer

Phase 3 Unknown

Nasopharyngeal Neoplasms

NCT01735409 2014-01-28

ABX-DDP-Dose

Phase 1/2 Unknown

Nasopharyngeal Neoplasms

NCT00943891 2014-01-22

A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal Cancer

GastrointestinalHead & Neck

Nasopharyngeal Neoplasms, Colorectal Neoplasms

NCT01347424 2013-12-09

Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

Phase 2 Unknown

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Nasopharyngeal Neoplasms

NCT01806272 2013-03-29

Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis

Phase 2 Unknown

Nasopharyngeal Neoplasms, Stomatitis

NCT01689558 2013-03-12

Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer

Phase 2/3 Unknown

Nasopharyngeal Neoplasms

NCT01312311 2011-03-10

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

Phase 2 Unknown

Nasopharyngeal Neoplasms

NCT00363831 2010-07-28

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Neoplasms

NCT00304694 2006-03-20

Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients

Nasopharyngeal Neoplasms